Newpid Tablet (Clopidogrel Bisulfate)

Adult dosage

○ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment on the initiation day with a loading dose of 300mg of this medicine once daily, followed by an oral maintenance dose of 75mg once daily. Aspirin 75~325mg should be administered concomitantly with this medicine once daily. 3. In patients with atrial fibrillation, administer 75mg of this medicine orally once daily. Aspirin 75~100mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease and bleeding diathesis is limited. This medicine may be administered with or without food.

This drug prevents platelets from aggregating and prevents blood clotting. Before taking this medicine, you should consult your doctor if you have a genetic deficiency in the function of a specific enzyme (CYP2C19), as this may reduce its effectiveness. Additionally, using this drug with medications that enhance the activity of this enzyme may increase the risk of bleeding, so co-administration should be avoided. People allergic to this drug or its components, patients with bleeding, severely impaired liver function, nursing women, and patients with certain genetic lactose intolerance should not take this medication. Patients at high risk of bleeding or with bleeding disorders need to use this medicine cautiously and should inform their doctor immediately if bleeding symptoms occur. Particularly, patients scheduled for surgery should stop taking this medication 5-7 days before the surgery and resume once hemostasis is achieved. This medication may increase the risk of bleeding when taken with other medications that also pose a bleeding risk, so caution should be exercised. During treatment, patients should remain vigilant for bleeding symptoms, and if bleeding is suspected, it should be confirmed with blood tests, etc. Rarely, thrombocytopenia or serious blood abnormalities may occur; therefore, immediately consult a healthcare professional if symptoms of infection or fever arise. This medication may cause side effects such as indigestion, abdominal pain, diarrhea, headache, dizziness, and skin rash, and you should consult your doctor if symptoms are severe. During pregnancy, it is advisable to use this drug only when absolutely necessary, and it is better to discontinue use before childbirth due to the risk of bleeding. If you are breastfeeding, as this drug may be secreted in breast milk, you should consult your doctor about whether to continue or stop breastfeeding. Safety in children has not been established, so it is generally not used in pediatric patients. Elderly patients may have reduced kidney and liver function; thus, dosage adjustment and condition monitoring are necessary. Overdosing may increase the risk of bleeding, and there is no specific antidote, so treatment such as platelet transfusion may be necessary in case of bleeding. This medication should be kept out of the reach of children, and it is advisable to avoid transferring it to other containers. While on this medication, you must inform healthcare personnel if you are starting new medications or undergoing surgery.

• Hemorrhage
• gastrointestinal bleeding
• purpura
• contusion
• hematoma
• epistaxis
• hematoma
• hematuria
• intraocular hemorrhage
• intracranial hemorrhage

This medication may be sensitive to air or moisture, so it must be stored in a sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This will help maintain the effectiveness and safety of the medication for a long time.

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle